Deven Choksey's research report on Fineotex Chemical
Fineotex Chemical reported revenue stood at INR 1,198 Mn., down 21.7% YoY (-4.9% QoQ), sharply below our estimates led by softness in FMCG and hygiene segment volumes, compounded by delay in deliveries in export markets like Bangladesh. EBITDA stood at INR 213 Mn., down 44.4% YoY (-37.9% QoQ), sharply below our estimates led by contraction of gross margins and higher operating expenditure. EBITDA margin contracted 725bps YoY (-946bps QoQ) to 17.8%. Net profit stood at INR 200 Mn., down 33.7% YoY (-27.7% QoQ), resulting in PAT margin declining by 311bps YoY (-530bps QoQ) to 16.8%. We have revised our FY26E/FY27E EPS estimates by -20.5% / -19.8% respectively, reflecting softness in the FMCG and hygiene segments, persistent delay in export orders amid geopolitical disruptions, and margin headwinds from front loading of operating expenses. Despite near-term challenges, we remain constructive on FCL’s long-term growth trajectory led by healthy order pipeline, high-potential verticals including oil & gas and water treatment and on the back of expected customer additions.
OutlookWe value Fineotex chemicals at 22.0x FY27E EPS, implying a target price of INR 294. We reiterate and maintain our “BUY” rating on the stock.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.